CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: cefalotin
Accession: CHEBI:124991
browse the term
Definition: A semisynthetic, first-generation cephalosporin antibiotic with acetoxymethyl and (2-thienylacetyl)nitrilo moieties at positions 3 and 7, respectively, of the core structure. Administered parenterally during surgery and to treat a wide spectrum of blood infections.
Synonyms: related_synonym: (6R,7R)-3-(acetoxymethyl)-8-oxo-7-(thiophen-2-ylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 3-Acetoxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acid; 7-(2-Thienylacetamido)cephalosporanic acid; 7-(Thiophene-2-acetamido)cephalosporin; 7beta-(thiophen-2-ylacetamido)-3-acetoxymethyl-3,4-didehydrocepham-4-carboxylic acid; CET; Cefalothin; Cephalothin; Cephalotin; cefalotina; cefalotine; cefalotinum
alt_id: CHEBI:41547; CHEBI:50895
xref: Beilstein:945586; CAS:153-61-7; DrugBank:DB00456; HMDB:HMDB0014599
xref_mesh: MESH:D002512
xref: Patent:FR1384197; Patent:US3218318; Reaxys:945586; drugcentral:574; kegg.compound:C07761; kegg.drug:D07635; lincs.smallmolecule:LSM-15184; pdb-ccd:CLS; pubmed:10930630; pubmed:12569987; pubmed:12833570; pubmed:1384868; pubmed:13963283; pubmed:1701026; pubmed:2083978; pubmed:23472927; pubmed:23680238; pubmed:29017833; pubmed:6176550; wikipedia.en:Cephalothin
chemrof_formula: C16H16N2O6S2
chemrof_inchi: InChI=1S/C16H16N2O6S2/c1-8(19)24-6-9-7-26-15-12(14(21)18(15)13(9)16(22)23)17-11(20)5-10-3-2-4-25-10/h2-4,12,15H,5-7H2,1H3,(H,17,20)(H,22,23)/t12-,15-/m1/s1
chemrof_inchikey: XIURVHNZVLADCM-IUODEOHRSA-N
chemrof_smiles: [H][C@]12SCC(COC(C)=O)=C(C(=O)O)N1C(=O)[C@@]2([H])NC(=O)Cc1cccs1
cyclic_relationship: is_conjugate_acid_of CHEBI:50897
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of ABCB11 mRNA
CTD
PMID:24657338
NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:74,424,979...74,520,581
G
Abcc2
ATP binding cassette subfamily C member 2
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of ABCC2 mRNA
CTD
PMID:24657338
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471
G
Abcc3
ATP binding cassette subfamily C member 3
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of ABCC3 mRNA
CTD
PMID:24657338
NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
Cephalothin results in increased expression of BAX protein
CTD
PMID:15012731
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
G
Casp3
caspase 3
multiple interactions
ISO
Cephalothin results in increased cleavage of and results in increased activity of CASP3 protein
CTD
PMID:15012731
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in decreased expression of CYP8B1 mRNA
CTD
PMID:24657338
NCBI chr 8:130,455,622...130,457,592
Ensembl chr 8:130,442,503...130,457,689
G
Fgf19
fibroblast growth factor 19
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of FGF15 mRNA
CTD
PMID:24657338
NCBI chr 1:209,485,813...209,490,267
Ensembl chr 1:209,485,813...209,490,267
G
Npc1l1
NPC1 like intracellular cholesterol transporter 1
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of NPC1L1 mRNA
CTD
PMID:24657338
NCBI chr14:85,285,387...85,305,050
Ensembl chr14:85,285,390...85,305,050
G
Nr5a2
nuclear receptor subfamily 5, group A, member 2
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of NR5A2 mRNA
CTD
PMID:24657338
NCBI chr13:50,865,253...50,985,107
Ensembl chr13:50,867,920...50,984,938
G
Slc10a1
solute carrier family 10 member 1
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of SLC10A1 mRNA
CTD
PMID:24657338
NCBI chr 6:106,344,319...106,357,944
Ensembl chr 6:106,344,319...106,357,944
G
Slc25a20
solute carrier family 25 member 20
multiple interactions
EXP
Cephalothin binds to and results in decreased activity of SLC25A20 protein; Cephalothin inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine]
CTD
PMID:18452908
NCBI chr 8:118,243,573...118,265,027
Ensembl chr 8:118,243,519...118,265,027
G
Slc51b
SLC51 subunit beta
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in decreased expression of SLC51B mRNA
CTD
PMID:24657338
NCBI chr 8:74,827,047...74,835,109
Ensembl chr 8:74,827,047...74,835,109
G
Slco1b2
solute carrier organic anion transporter family member 1B2
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of SLCO1B2 mRNA
CTD
PMID:24657338
NCBI chr 4:176,282,577...176,355,557
Ensembl chr 4:176,282,584...176,351,083
G
Tp53
tumor protein p53
increases expression
ISO
Cephalothin results in increased expression of TP53 protein
CTD
PMID:15012731
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
G
Vdr
vitamin D receptor
multiple interactions
ISO
[Cephalothin co-treated with Neomycin] results in increased expression of VDR mRNA
CTD
PMID:24657338
NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:130,866,745...130,916,757
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all